Starting in 2015, psychiatrists will have to juggle antidepressant selections for Medicare patients. What might this mean for your patients?
Insurers appear to have plenty of leeway to continue—or even expand—the kind of anti-psychiatrist policies at the core of 2 lawsuits filed last year. Details here.
Come next year, psychiatrists will start seeing patients who have purchased new individual and small-group health plans on the state exchanges mandated by the Affordable Care Act.
The emergence of accountable care organizations (ACOs) may spur changes in psychiatric care, especially among office-based practitioners.
Cedars, the preeminent private hospital in L.A. and considered the “hospital to the Hollywood stars,” said it would continue staffing of psychiatric support that is an adjunct to patient care throughout the medical center.
The response of psychiatrists to Medicare’s continued inhospitability to psychiatrists in 2012 is cautious.
Medicare announced in October that it would pay for depression screening in primary care settings that have “staff-assisted depression care supports” in place to ensure accurate diagnosis, effective treatment, and follow-up.
A new Medicaid demonstration program slated to begin next year will pilot a solution to the problem of “psychiatric boarding,” which has plagued general hospitals for many years.
The proposed Conditions of Participation (CoPs) from Medicare for community mental health centers (CMHCs) could expand the role and responsibilities of psychiatrists both in and beyond Medicare facilities.
The White House Office of National Drug Control Policy will work with Congress to pass new legislation requiring all physicians with Drug Enforcement Administration (DEA) registrations to undergo mandatory education on the use of long-acting and extended-release opioids.